Welcome to our Corporate client solution
Your IP is registered with the company mentioned above and provides access to Life Science Sweden.
Tecknar licensavtal med bioteknikbolaget Omnis Pharmaceutical.
Aktien faller och analytiker spekulerar om problem i FDA-utredning.